-
Alternative_name
N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2E-propenamide
-
Description
Cell-permeable. FK-866 is a highly specific non-competitive inhibitor of Nicotinamide phosphoribosyltransferase (NAMPT) (Ki = 0.4 nM), causing gradual NAD+ depletion. NAMPT functions as an intra-cellular and extra-cellular NAD biosynthetic enzyme that is important for regulating metabolism and stress resistance through sirtuins and other NAD-consuming regulators. NAD+ depletion by FK-866 directs delayed cell death by apoptosis in Hep-G2 human liver carcinoma cells (IC₅₀ = ~1 nM).
-
CAS Number
658084-64-1
-
Structure Available
Yes
-
Salt Form
No
-
Molecular Formula
C₂₄H₂₉N₃O₂
-
Molecular Weight
391.51
-
Cell Permeable
Yes
-
Purity
≥98% by NMR
-
Solubilities
DMSO (>30 mg/ml) and Ethanol
-
Handling
Protect from light and air
-
Tag Line
A highly specific non-competitive inhibitor of Nicotinamide phosphoribosyltransferase (NAMPT)
-
Storage Condition
-20°C
-
Shipping Condition
gel pack
-
Shelf Life
36 months
-
PubChem CID
6914657
-
-
SMILES
C1CN(CCC1CCCCNC(=O)C=CC2=CN=CC=C2)C(=O)C3=CC=CC=C3
-
InChi
InChI=1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13- 17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14, 16-18H2,(H,26,28)/b12-11+
-
InChi Key
KPBNHDGDUADAGP-VAWYXSNFSA-N
-
-
MSDS Available
Yes